Effects of nebivolol and ivabradine on myocardial ischemia in patients (pts) with COPD and stable angina during 24-hour ambulatory Holter ECG monitoring. Source: International Congress 2017 – Extrapulmonary comorbidities in COPD Year: 2017
Myocardial ischemia in patients (pts) with COPD and stable angina during 24-hour ambulatory Holter ECG monitoring Source: International Congress 2015 – COPD: interesting notes Year: 2015
Assessment of cardiac events via 24-hour electrocardiographic (Holter) monitoring with cilomilast in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 66s Year: 2003
Safety of nebivolol and bisoprolol in patients (pts) with COPD and stable angina. Source: International Congress 2018 – Cardiovascular morbidities in COPD Year: 2018
Late Breaking Abstract - Holter ECG-based arrhythmia and heart rate analysis in patients with COPD receiving a fixed-dose combination of tiotropium/olodaterol versus its monocomponents Source: International Congress 2018 – COPD: from LABA/ICS to LABA/LAMA/ICS Year: 2018
Effects of bisoprolol and nebivolol on the left ventricular diastolic function in patients (pts) with COPD and stable angina. Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD Year: 2020
Holter ECG monitoring during bronchofiberoscopy in patients with asthma Source: Eur Respir J 2005; 26: Suppl. 49, 506s Year: 2005
Sleep architecture in COPD patients during salmeterol versus tiotropium bromide treatment Source: Eur Respir J 2006; 28: Suppl. 50, 199s Year: 2006
Effects of acute dual bronchodilator treatment (tiotropium + olodaterol) on cardiopulmonary interactions in hyperinflated patients with COPD Source: International Congress 2018 – Advances in exercise physiopathology Year: 2018
Effect of formoterol alone and in combination with aclidinium on electrocardiograms in dogs Source: Annual Congress 2012 - COPD treatments: efficacy and safety Year: 2012
Evaluation of electrocardiographic (ECG) changes in subjects with severe asthma or COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 300s Year: 2005
Effects of nebivolol and ivabradine on the left ventricular diastolic function in patients (pts) with COPD and stable angina Source: International Congress 2014 – COPD markers Year: 2014
Formoterol or tiotropium bromide do not influence isolated nocturnal hypoxemia in stable COPD Source: Eur Respir J 2005; 26: Suppl. 49, 294s Year: 2005
Sleep architecture in COPD patients during salmeterol versus ipratropium bromide treatment Source: Eur Respir J 2004; 24: Suppl. 48, 113s Year: 2004
Influence of higher than conventional doses of salbutamol or ipratropium bromide on bronchodilation induced by a regular treatment with tiotropium in patients suffering from stable COPD Source: Eur Respir J 2007; 30: Suppl. 51, 356s Year: 2007
Improvement of dyspnoea following of six months treatment with tiotropium but not with salmeterol in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 26s Year: 2001
Comparative study of two years treatment with salmeterol alone and in combination with ipratropium bromide and beclometazone dipropionate in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 342s Year: 2004
Effect of fluticasone propionate/salmeterol on exercise endurance in moderate-severe COPD Source: Annual Congress 2012 - COPD treatment and varia Year: 2012
Improvement in dyspnea with fluticasone/salmeterol compared with salmeterol or ipratropium in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 88s Year: 2004
NVA237, a once-daily inhaled anticholinergic, provides 24-hour bronchodilator efficacy in patients with moderate-to-severe COPD Source: Eur Respir J 2006; 28: Suppl. 50, 527s Year: 2006